Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pahl

Showing results (41-50 of 174) with videos related to

Pageof 18
Sort By:
Pathologie-Biologie|January 1, 1996
Reactive oxygen intermediates as second messengers of a general pathogen responseP A Baeuerle, R A Rupec, H L Pahl
Experimental Hematology|November 1, 1991
Optimization of transient transfection into human myeloid cell lines using a luciferase reporter geneH L Pahl, T C Burn, D G Tenen
Experimental Hematology|May 30, 2001
STAT3 is constitutively active in some patients with Polycythemia rubra veraS Röder, C Steimle, G Meinhardt, et al.
Neuroscience Letters|March 15, 2006
Propentofylline attenuates vincristine-induced peripheral neuropathy in the ratS M Sweitzer, J L Pahl, J A DeLeo
Blood|February 15, 1992
Characterization of the myeloid-specific CD11b promoterH L Pahl, A G Rosmarin, D G Tenen
Haematologica|June 22, 2014
NFE2 regulates transcription of multiple enzymes in the heme biosynthesis pathwayLara Rheinemann, Thalia S Seeger, Julius Wehrle, et al.
Leukemia|March 27, 2025
Malignant JAK-signaling: at the interface of inflammation and malignant transformationFlorian Perner, Heike L Pahl, Robert Zeiser, et al.
Biological Chemistry|November 5, 1997
Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaBG Lyss, T J Schmidt, I Merfort, et al.
Terapevticheskii Arkhiv|January 1, 1982
[Importance of physical training for the differential treatment of arterial hypertension]U Priebe, E Kube, U Wagner, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditionsT J Schmidt, G Lyss, H L Pahl, et al.
Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Pathologie-Biologie|January 1, 1996
Reactive oxygen intermediates as second messengers of a general pathogen responseP A Baeuerle, R A Rupec, H L Pahl
Experimental Hematology|November 1, 1991
Optimization of transient transfection into human myeloid cell lines using a luciferase reporter geneH L Pahl, T C Burn, D G Tenen
Experimental Hematology|May 30, 2001
STAT3 is constitutively active in some patients with Polycythemia rubra veraS Röder, C Steimle, G Meinhardt, et al.
Neuroscience Letters|March 15, 2006
Propentofylline attenuates vincristine-induced peripheral neuropathy in the ratS M Sweitzer, J L Pahl, J A DeLeo
Blood|February 15, 1992
Characterization of the myeloid-specific CD11b promoterH L Pahl, A G Rosmarin, D G Tenen
Haematologica|June 22, 2014
NFE2 regulates transcription of multiple enzymes in the heme biosynthesis pathwayLara Rheinemann, Thalia S Seeger, Julius Wehrle, et al.
Leukemia|March 27, 2025
Malignant JAK-signaling: at the interface of inflammation and malignant transformationFlorian Perner, Heike L Pahl, Robert Zeiser, et al.
Biological Chemistry|November 5, 1997
Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaBG Lyss, T J Schmidt, I Merfort, et al.
Terapevticheskii Arkhiv|January 1, 1982
[Importance of physical training for the differential treatment of arterial hypertension]U Priebe, E Kube, U Wagner, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditionsT J Schmidt, G Lyss, H L Pahl, et al.
Pageof 18